Neurology Central

Novartis to seek US approval of siponimod for SPMS: industry news round up

0
Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.
Our pick of the highlights include:
Share:

Leave A Comment